Agilent, Malaysia Team Up to Promote Biotech | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today signed a memorandum of understanding with the Malaysian government to promote and develop biotechnology in that country.

The MOU was reached through the Malaysian Institute of Pharmaceuticals and Nutraceuticals, or IPHARM, an agency under the Ministry of Science, Technology, and Innovation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.